![Mitchell Keegan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Keegan
Keine laufenden Positionen mehr
Profil
Mitchell Keegan worked as a Senior Director-Drug Development at Gloucester Pharmaceuticals, Inc. from 2008 to 2008.
Prior to that, he was a Pharmacology Director at CombinatoRx, Inc. from 2001 to 2005 and a Study Director at Toxikon Corp.
in 2001.
From 2008 to 2011, he worked as a Vice President-Drug Development at Curis, Inc. Keegan received his undergraduate degree from The University of Sydney and his doctorate from the University of Western Sydney.
Ehemalige bekannte Positionen von Mitchell Keegan
| Unternehmen | Position | Ende |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 15.10.2011 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Corporate Officer/Principal | 01.03.2008 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Corporate Officer/Principal | 01.04.2005 |
Toxikon Corp.
 Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Provides life science and laboratory services | Corporate Officer/Principal | 01.12.2001 |
Ausbildung von Mitchell Keegan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toxikon Corp.
Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Provides life science and laboratory services | Commercial Services |
